Drug Profile
Research programme: Chlamydia vaccine - Antigen Discovery
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Antigen Discovery
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Chlamydial infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Chlamydial-infections in USA
- 21 Sep 2009 Early research in Chlamydial infections in USA (unspecified route)